https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53913 Wed 28 Feb 2024 15:58:52 AEDT ]]> A road map for the treatment of pediatric diffuse midline glioma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53880 Fri 19 Jan 2024 12:44:57 AEDT ]]>